CSR

In pursuit of its?human health care philosophy, Eisai China Inc. strives to maintain the highest GMP standard in manufacturing products and strictly adheres to the highest level of ethics and compliance. Through this commitment, Eisai China Inc not only provides high-quality, eco-friendly, safe and satisfactory products and services to patients and their families, but also proactively contribute to society by supporting programs and activities that help promote the advancement of medical sciences (e.g. “Eisai Scholarship Award”), increase awareness about diseases (e.g. “Yellow Handkerchief Love Action”), and provide aide in times of disasters.

May

Eisai China donated 700,000 yuan worth of digestive system medicine to Anxiang County, Hunan Province.

南宫NG28(中国)官方网站-登录入口

April

Eisai China donated 50,000 yuan to the “Just Charity – Jing ‘an Liren Hui Special Fund” to fund public welfare activities related to women and children.

南宫NG28(中国)官方网站-登录入口

March

Eisai China won the 2023 Charity Enterprise Award at the 8th China Charity Annual Meeting

南宫NG28(中国)官方网站-登录入口

Eisai China awarded “Jiangsu Green Factory”

南宫NG28(中国)官方网站-登录入口

Eisai China Scholarship Award Ceremony was successfully held at School of Basic Medical, Fudan University

南宫NG28(中国)官方网站-登录入口

Eisai China Scholarship Award Ceremony was successfully held at School of Business Administration, Shenyang Pharmaceutical University

南宫NG28(中国)官方网站-登录入口

February

Eisai to boost initiatives on greenhouse gas reduction, aiming to achieve net zero by 2050.

January

Top Employer China 2024

南宫NG28(中国)官方网站-登录入口

Eisai China Scholarship Award Ceremony was successfully held at School of Pharmacy, Xi’an Jiaotong University.

南宫NG28(中国)官方网站-登录入口

2023

December

Eisai China Scholarship Award Ceremony was successfully held at School of Pharmacy, China Pharmaceutical University.

南宫NG28(中国)官方网站-登录入口

Eisai China Scholarship Award Ceremony was successfully held at Peking University Health Science Center

南宫NG28(中国)官方网站-登录入口

November

At the Expo, Eisai China together with Sinotau, KingMed, HTA Co., Medi Trust and Yin Fa Tong jointly proposed and built China’s brain health industry ecosystem.

October

The OSD of Suzhou Plant won the Suzhou City-level Model Intelligent Workshop.

September

On World Alzheimer’s Day, Eisai has released a dementia awareness video, “Life Goes On 2023: Two Memories, One Story” globally.
南宫NG28(中国)官方网站-登录入口


Alzheimer’s Disease Handbook 2023 released.
南宫NG28(中国)官方网站-登录入口

 

“Le-Guan-Xiang-Qian”–Patient Assistance Program for Liver Cancer in County Areas is launched.

南宫NG28(中国)官方网站-登录入口

 

July

Eisai China and Shanghai Yinfatong Internet Hospital (a subsidiary of Unlimit Health Limited) launched the “Memory and Love” – A Brain Health Care Program for the Elderly.

南宫NG28(中国)官方网站-登录入口

 

Eisai China Calls for “Concern for Brain Health, Early Detection, Early Diagnosis, Early Intervention” at the “2023China Brain Health Conference.”

南宫NG28(中国)官方网站-登录入口

 

June

Suzhou plant successfully completed the 2022 greenhouse gas and product carbon foot-printing.
南宫NG28(中国)官方网站-登录入口

Suzhou plant successfully passed the energy management system certification.

南宫NG28(中国)官方网站-登录入口

Eisai China Scholarship Award Ceremony was successfully held at School of Business Administration, Shenyang Pharmaceutical University.

南宫NG28(中国)官方网站-登录入口

 

March

The “Hai-Yun-Xin-Sheng” breast cancer PAP

In order to help more patients diagnosed with breast cancer to receive timely and effective treatment, reduce their financial burden and prolong their lives, the China Primary Health Care Foundation launched the “Hai-Yun-Xin-Sheng” Breast Cancer Patient Assistance Project (PAP) in September 2020, and Eisai provided free drug Halaven to the China Primary Health Care Foundation. As of March 2023, there are 207 low-insurance patients and 2,204 low-income patients with 25,687 injection for a cumulative donation value of RMB 102.2 million.

 

“Wei-Ai-Xin-Sheng” PAP

In order to help more patients diagnosed with hepatocellular carcinoma to receive timely and effective treatment, reduce their financial burden and prolong their lives, China Charity Federation launched the “Wei-Ai-Xin-Sheng” Patient Assistance Project (PAP) in December 2022, and Eisai provided free Levima to China Charity Federation, which aims to help patients with hepatocellular carcinoma to receive more durable and effective medical treatment and improve their quality of life.

 

January

Top Employer China 2023

南宫NG28(中国)官方网站-登录入口